Context Therapeutics (CNTX) Earnings Date, Estimates & Call Transcripts $0.87 +0.01 (+0.82%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.86 0.00 (-0.53%) As of 05/2/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Context Therapeutics Earnings Summary Upcoming Earnings DateMay. 14EstimatedConsensus EPS (Mar. 20) -$0.05 Actual EPS (Mar. 20) -$0.04 Beat By $0.01 Context Therapeutics announced Q4 2024 earnings on March 20, 2025, reporting an EPS of -$0.04, which beat the consensus estimate of -$0.05 by $0.01. With a trailing EPS of -$0.49, Context Therapeutics' earnings are expected to grow next year, from ($0.51) to ($0.31) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) ReportCNTX Upcoming EarningsContext Therapeutics' Q1 2025 earnings is scheduled for Wednesday, May 14, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Context Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Context Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCNTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Context Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.05-$0.05-$0.05Q2 20251-$0.06-$0.06-$0.06Q3 20252-$0.07-$0.05-$0.06Q4 20252-$0.08-$0.05-$0.07 FY 2025 6 -$0.26 -$0.21 -$0.24 Q1 20261-$0.08-$0.08-$0.08Q2 20261-$0.09-$0.09-$0.09Q3 20261-$0.08-$0.08-$0.08Q4 20261-$0.07-$0.07-$0.07 Context Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/14/2025(Estimated)--------3/20/2025Q4 2024-$0.05-$0.04+$0.01---11/6/2024--$0.11-$0.22 -$0.11-$0.22--8/7/2024--$0.08-$0.04+$0.04-$0.04--5/8/2024Q1 2024-$0.38-$0.23+$0.15-$0.23--3/21/2024Q4 2023-$0.35-$0.42 -$0.07-$0.42--11/9/2023Q3 2023-$0.30-$0.37 -$0.07-$0.37--8/9/2023Q2 2023-$0.20-$0.31 -$0.11-$0.31--5/10/2023Q1 2023-$0.19-$0.40 -$0.21-$0.40-- Context Therapeutics Earnings - Frequently Asked Questions When is Context Therapeutics's earnings date? Context Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 14th, 2025 based off last year's report dates. Learn more on CNTX's earnings history. Did Context Therapeutics beat their earnings estimates last quarter? In the previous quarter, Context Therapeutics (NASDAQ:CNTX) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.05) by $0.01. Learn more on analysts' earnings estimate vs. CNTX's actual earnings. How much profit does Context Therapeutics generate each year? Context Therapeutics (NASDAQ:CNTX) has a recorded net income of -$23.96 million. CNTX has generated -$0.49 earnings per share over the last four quarters. What is Context Therapeutics's EPS forecast for next year? Context Therapeutics's earnings are expected to grow from ($0.51) per share to ($0.31) per share in the next year. More Earnings Resources from MarketBeat Related Companies OLMA Earnings Results TRDA Earnings Results BNTC Earnings Results RNAC Earnings Results MBX Earnings Results SEPN Earnings Results GLUE Earnings Results PROK Earnings Results ATAI Earnings Results ATYR Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback PlanMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of Earnings This page (NASDAQ:CNTX) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Context Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Context Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CNTX Stock Free CNTX Stock Alerts